These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37850296)

  • 1. [Statement of the II meeting of the expert council on prevention of urinary stone disease (02.12.2022, Moscow)].
    Urologiia; 2023 Sep; (4):150. PubMed ID: 37850296
    [No Abstract]   [Full Text] [Related]  

  • 2. [Interdisciplinary approach for prevention of recurrent urinary stone disease].
    Saenko VS; Pesegov SV
    Urologiia; 2020 Nov; (5):87-92. PubMed ID: 33185354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The methodology of remote monitoring of patients with urinary stone disease: development and primary approbation].
    Lebedev GS; Shaderkin IA; Gazimiev MA; Rudenko VI; I DV; Alfimov AE; Vladzimirsky AV; Gazimiev AM
    Urologiia; 2021 Nov; (5):26-34. PubMed ID: 34743428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical study on the effect of mineral waters containing bicarbonate on the risk of urinary stone formation in patients with multiple episodes of CaOx-urolithiasis.
    Karagülle O; Smorag U; Candir F; Gundermann G; Jonas U; Becker AJ; Gehrke A; Gutenbrunner C
    World J Urol; 2007 Jun; 25(3):315-23. PubMed ID: 17333204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of stone disease.
    Porena M; Guiggi P; Micheli C
    Urol Int; 2007; 79 Suppl 1():37-46. PubMed ID: 17726351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Urinary stone disease. Part IV. Recurrence prevention for urinary stone disease].
    Saenko VS; Gazimiev MA; Pesegov SV; Alyaev YG
    Urologiia; 2019 Jun; (2):88-96. PubMed ID: 31162908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of dynamic observation in the prevention of recurrences of stone formation].
    Dzeranov NK; Darenkov AF; Konstantinova OV; Beshliev DA; Borisik VI; Golovanov SA; Drozhzheva VV
    Urol Nefrol (Mosk); 1998; (2):12-4. PubMed ID: 9577694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Resolution of the Expert Council on the metaphylaxis of urolithiasis].
    Urologiia; 2022 Mar; (1):126. PubMed ID: 35274873
    [No Abstract]   [Full Text] [Related]  

  • 9. HIGH INCIDENCE OF UROLITHIASIS AND UROLOGICAL DISEASE AMONG THE INHABITANTS IN SAUDI ARABIA.
    HAROUN AE
    J Egypt Med Assoc; 1964; 47():726-31. PubMed ID: 14271918
    [No Abstract]   [Full Text] [Related]  

  • 10. [Ureterocele and urolithiasis].
    MARZOLI GP
    Z Urol; 1961 May; 54():279-80. PubMed ID: 13767702
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical study on cystinuria in children--the stone management and the prevention of calculi recurrence].
    Asanuma H; Nakai H; Takeda M; Shishido S; Kawamura T; Nagakura K; Yamafuji M
    Nihon Hinyokika Gakkai Zasshi; 1998 Sep; 89(9):758-65. PubMed ID: 9796255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Furadantin treatment of experimental urinary tract infection and its influence on stone growth; experimental urolithiasis. XI.
    MILLER GH; CHAPMAN WH; SEIBUTIS L; VERMEULEN CW
    J Urol; 1956 Jul; 76(1):42-6. PubMed ID: 13332760
    [No Abstract]   [Full Text] [Related]  

  • 13. [On anomalies of the lumbosacral segment of the spine in patients with urolithiasis].
    NIAN'KOVSKII AM
    Urol Mosc; 1961; 26():57-9. PubMed ID: 14479410
    [No Abstract]   [Full Text] [Related]  

  • 14. [Separate examination of the tubular reasorption of water in the kidneys in the course of urolithiasis].
    SCHUK O; HRADEC E
    J Urol Medicale Chir; 1959 Jun; 65():468-72. PubMed ID: 14443729
    [No Abstract]   [Full Text] [Related]  

  • 15. [What kind of stone prevention for whom? Risk-adjusted metaphylaxis following urinary stone disease].
    Straub M
    Urologe A; 2006 Nov; 45(11):1387-8, 1390-1. PubMed ID: 17082926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The prevention of urolithiasis based on the most recent research].
    KLIKA M
    Munch Med Wochenschr; 1960 Jul; 102():1488-93 contd. PubMed ID: 14409849
    [No Abstract]   [Full Text] [Related]  

  • 17. Urinary stone disease: closing the heritability gap by challenging conventional Mendelian inheritance.
    Halbritter J
    Kidney Int; 2023 Nov; 104(5):882-885. PubMed ID: 37863636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [On the drug therapy and prophylaxis of urolithiasis].
    BAUER KM
    Fortschr Med; 1961 Dec; 79():683-4. PubMed ID: 13865878
    [No Abstract]   [Full Text] [Related]  

  • 19. Recurrence prevention in patients with urinary tract stone disease.
    Tiselius HG
    ScientificWorldJournal; 2004 Jan; 4():35-41. PubMed ID: 14755100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic evaluation and medical management of upper urinary tract stone disease. Guidelines from the Scandinavian Cooperative Group for Urinary Stones.
    Osther PJ; Grenabo L; Haraldsson G; Holmberg G; Lindell O; Mogensen P; Schultz A; Ulvik NM
    Scand J Urol Nephrol; 1999 Dec; 33(6):372-81. PubMed ID: 10636576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.